Clinical Trial Update: Ixabepilone and Cyclophosphamide as Neoadjuvant Therapy in HER-2 Negative Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluated ixabepilone with cyclophosphamide as neoadjuvant therapy for HER-2 negative breast cancer; results have been posted after com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Ixabepilone (ixabepilone)

Snippet

Sponsor: SCRI Development Innovations, LLC | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2014-11-27